Study malaria risk factors in pregnancy and young children
Part of Infections clinical trials.
This study looks at why some people get malaria during pregnancy, and how young children’s bodies respond early in life. It may help researchers understand who is more likely to get malaria and why, which could guide future prevention and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) live in Ouelessebougou for at least one year before enrollment
- You are either pregnant (age 15–45), a newborn from that pregnancy, or a child age 3 or younger
- OR you are a child age 0–10 with fever, either admitted to the hospital or seen as an outpatient in the study area
- OR you are a pregnant person age 15–25 in Ouelessebougou/Gabriel Toure Hospital area, including specific preeclampsia case/control needs
- You (or your child’s parent/guardian) understand the study and agree to participate and allow sample storage
- You do not have a serious long-term illness besides malaria (based on exam/history)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry is collecting information about pregnancies in Mali to help improve health for mothers and babies. You can join either as part of a general community survey or as a pregnant woman receiving care at a health center in Kalifabougou.
This study looks at lab tests for malaria vaccine candidates in pregnant women who currently have malaria. It may help researchers understand which vaccine approaches are safest and most promising for pregnancy.
This study looks at how malaria spreads in Mozambique by testing children and pregnant women with fever. If you or your child may have malaria, participating could help researchers understand and fight the disease better.
This study looks at how the body's immune system responds to infections like malaria and other germs, especially in young children and newborns. By comparing children with and without fever, and mothers and their newborns, researchers hope to understand how co-infections affect health.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This study tests if giving schoolchildren malaria-prevention medicine at certain times can lower malaria in the community. It might help protect your child and others from getting sick.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.